Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07278778 · ClinicalTrials.gov registry record · NA

Cancer Care Companion

A NA study of Pediatric Cancer, sponsored by Washington University School of Medicine.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07278778 is a NA study of Pediatric Cancer that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 40 participants, below the 1,490-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07278778, a NA study of Pediatric Cancer, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study invites parents of children with cancer to use an electronic health record (EHR)-based communication tool, called the Cancer Care Companion, and assess the acceptability, appropriateness, and feasibility of the tool.

Conditions Studied

Interventions

  • OTHER Cancer Care Companion

Study Locations (1)

Missouri

  • Washington University School of Medicine/Saint Louis Children's Hospital - St Louis

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-02-04
Est. Completion 2027-08-31
Phase NA

What the Registry Record Tells You About NCT07278778

The ClinicalTrials.gov registry entry for NCT07278778 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,490-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pediatric Cancer appearing as the primary indexed condition, and to 1 intervention - of which Cancer Care Companion is the first listed.

NCT07278778 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT07278778 about?

NCT07278778 is a clinical study titled "Cancer Care Companion". This study invites parents of children with cancer to use an electronic health record (EHR)-based communication tool, called the Cancer Care Companion, and assess the acceptability, appropriateness, and feasibility of the tool.

What is the current status of trial NCT07278778?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-02-04. Estimated completion is 2027-08-31.

What conditions does trial NCT07278778 study?

This clinical trial studies the following conditions: Pediatric Cancer.

What interventions are being tested in trial NCT07278778?

The interventions under investigation include: Cancer Care Companion (OTHER).

Who is sponsoring clinical trial NCT07278778?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07278778 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pediatric Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.